| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 801 | ¥6.22 | +0.81% | -3.10% | ¥4.3B $593.99M · €517.90M | 8.26M shrs ¥51.39M | ||
| 802 | ¥8.93 | +1.02% | +1.65% | ¥4.3B $593.58M · €517.54M | 6.75M shrs ¥60.32M | ||
| 803 | ₹862.30 | -1.08% | +3.87% | ₹49.35B $592.14M · €516.29M | 2.13K shrs ₹1.83M | ||
| 804 | $4.94 | -4.82% | -3.90% | $590.84M €515.16M | 7.79M shrs $38.5M | ||
| 805 | ¥9.68 | +1.36% | -3.36% | ¥4.25B $586.54M · €511.41M | 3.83M shrs ¥37.07M | ||
| 806 | ¥27.28 | +0.29% | -2.99% | ¥4.24B $585.08M · €510.14M | 2.52M shrs ¥68.84M | ||
| 807 | HK$10.00 | +0.40% | -9.57% | HK$4.57B $584.73M · €509.83M | 7.05M shrs HK$70.47M | ||
| 808 | HK$3.56 | +0.00% | -0.31% | HK$4.56B $583.63M · €508.86M | 871K shrs HK$3.1M | ||
| 809 | NT$75.50 | +1.21% | +5.01% | NT$18.77B $581.97M · €507.42M | 1.56M shrs NT$118.02M | ||
| 810 | ¥5.65 | +0.18% | +7.02% | ¥4.21B $581.40M · €506.92M | 18.19M shrs ¥102.76M | ||
| 811 | HK$5.64 | -1.23% | -4.03% | HK$4.53B $580.37M · €506.02M | 542K shrs HK$3.06M | ||
| 812 | $16.60 | -8.79% | +4.56% | $579.21M €505.02M | 849.32K shrs $14.1M | ||
| 813 | ¥3.25 | -0.61% | -5.43% | ¥4.18B $577.31M · €503.36M | 25.98M shrs ¥84.43M | ||
| 814 | ¥32.90 | +1.86% | -0.52% | ¥4.18B $576.98M · €503.07M | 281.4K shrs ¥9.26M | ||
| 815 | ₩13330.00 | -7.24% | -3.77% | ₩799.85B $575.89M · €502.12M | 601.88K shrs ₩8.02B | ||
| 816 | ¥28.79 | -0.24% | -1.83% | ¥4.17B $575.25M · €501.56M | 2.14M shrs ¥61.63M | ||
| 817 |  Laekna, Inc. 2105.HK🇭🇰HKD | HK$9.96 | +0.50% | -3.72% | HK$4.48B $572.84M · €499.46M | 2.73M shrs HK$27.22M | |
| 818 | ₹1034.80 | -0.78% | +1.80% | ₹47.66B $571.88M · €498.62M | 2.41K shrs ₹2.49M | ||
| 819 | ₹1034.70 | -0.93% | +1.45% | ₹47.65B $571.82M · €498.57M | 113.5K shrs ₹117.43M | ||
| 820 | ¥20.40 | +0.99% | +0.56% | ¥4.12B $568.06M · €495.29M | 4.43M shrs ¥90.47M | ||
| 821 | ¥15.58 | +1.37% | +0.06% | ¥4.11B $566.53M · €493.95M | 6.99M shrs ¥108.98M | ||
| 822 | ¥9.80 | +1.24% | +3.72% | ¥4.09B $564.76M · €492.42M | 2.54M shrs ¥24.89M | ||
| 823 | $7.93 | -5.82% | -0.81% | $564.54M €492.22M | 1.27M shrs $10.05M | ||
| 824 | ¥48.28 | -2.23% | -7.98% | ¥4.05B $558.81M · €487.22M | 1.33M shrs ¥64.38M | ||
| 825 | ¥8.12 | -0.49% | +8.32% | ¥4.04B $558.00M · €486.52M | 8.79M shrs ¥71.41M | ||
| 826 | $3.74 | -1.06% | +4.56% | $557.06M €485.70M | 1.15M shrs $4.31M | ||
| 827 | ₹438.35 | -3.91% | +11.38% | ₹46.37B $556.47M · €485.19M | 1.24M shrs ₹542.52M | ||
| 828 | ₹438.05 | -4.12% | +10.89% | ₹46.34B $556.09M · €484.86M | 76.12K shrs ₹33.34M | ||
| 829 | $29.93 | -1.06% | +7.53% | $553.77M €482.83M | 498.31K shrs $14.91M | ||
| 830 | MX$26.00 | +0.00% | +0.00% | MX$10.63B $552.76M · €481.95M | 16 shrs MX$416 | ||
| 831 | ¥13.73 | +1.33% | -14.84% | ¥4.01B $552.71M · €481.91M | 7.52M shrs ¥103.2M | ||
| 832 | $3.06 | -11.82% | +20.06% | $552.69M €481.89M | 4.46M shrs $13.66M | ||
| 833 | ¥5.19 | +0.19% | -3.76% | ¥3.99B $551.13M · €480.53M | 7.15M shrs ¥37.11M | ||
| 834 | SR 58.60 | -0.51% | -0.41% | SR 2.05B $547.62M · €477.47M | 56.36K shrs SR 3.3M | ||
| 835 | $29.00 | -0.45% | +7.03% | $547.21M €477.11M | 82.08K shrs $2.38M | ||
| 836 | ¥19.65 | +0.00% | +17.12% | ¥3.95B $545.75M · €475.84M | 2.94M shrs ¥57.79M | ||
| 837 | A$2.25 | -2.60% | +1.90% | A$839.19M $545.47M · €475.60M | 1.81M shrs A$4.07M | ||
| 838 | ¥36.52 | +0.05% | +10.35% | ¥3.95B $545.40M · €475.54M | 1.35M shrs ¥49.21M | ||
| 839 | $3.31 | -2.65% | +6.74% | $544.87M €475.07M | 1.33M shrs $4.41M | ||
| 840 | ¥4.83 | +1.26% | -3.49% | ¥3.95B $544.50M · €474.75M | 6.02M shrs ¥29.08M | ||
| 841 | ProKidney Corp. PROK🇺🇸USD | $1.80 | -2.70% | +5.00% | $543.71M €474.06M | 1.44M shrs $2.59M | |
| 842 | ₹413.20 | +0.38% | -1.17% | ₹45.11B $541.27M · €471.94M | 137.56K shrs ₹56.84M | ||
| 843 | ₹413.45 | +0.46% | -1.86% | ₹45.05B $540.62M · €471.37M | 18.16K shrs ₹7.51M | ||
| 844 | ¥8.98 | +1.13% | -4.86% | ¥3.91B $539.27M · €470.19M | 1.97M shrs ¥17.73M | ||
| 845 | $8.22 | -9.17% | +16.03% | $536.97M €468.18M | 1.38M shrs $11.36M | ||
| 846 | ¥7.58 | +1.47% | -6.87% | ¥3.87B $534.17M · €465.74M | 2.61M shrs ¥19.79M | ||
| 847 | ¥6.22 | +0.48% | -2.43% | ¥3.87B $533.84M · €465.45M | 6.72M shrs ¥41.81M | ||
| 848 | ¥32.20 | -0.03% | -3.03% | ¥3.86B $533.23M · €464.93M | 2.6M shrs ¥83.7M | ||
| 849 | HK$5.96 | +0.34% | +0.91% | HK$4.15B $531.49M · €463.40M | 258K shrs HK$1.54M | ||
| 850 | $3.25 | -7.41% | -0.99% | $529.93M €462.04M | 4.27M shrs $13.89M | ||
| 851 | ¥9.26 | +0.65% | +8.50% | ¥3.84B $529.92M · €462.04M | 10.36M shrs ¥95.89M | ||
| 852 | $42.09 | -0.73% | +1.60% | $527.85M €460.23M | 41.94K shrs $1.77M | ||
| 853 |  Altimmune, Inc. ALT🇺🇸USD | $2.71 | -7.19% | +8.25% | $527.02M €459.51M | 3.11M shrs $8.43M | |
| 854 | $5.13 | -3.02% | +27.74% | $526.64M €459.18M | 766.16K shrs $3.93M | ||
| 855 | ₩14250.00 | -0.70% | -8.60% | ₩730.49B $525.95M · €458.58M | 4.94K shrs ₩70.39M | ||
| 856 | ₩17850.00 | -1.44% | +5.42% | ₩729.9B $525.53M · €458.21M | 64.97K shrs ₩1.16B | ||
| 857 | ¥38.07 | -1.07% | +4.29% | ¥3.8B $524.74M · €457.52M | 3.5M shrs ¥133.19M | ||
| 858 | ₩16250.00 | -2.52% | -10.35% | ₩722.26B $520.03M · €453.41M | 225.37K shrs ₩3.66B | ||
| 859 |  Valneva SE VALN🇺🇸USD | $5.48 | -3.35% | -5.74% | $519.63M €453.07M | 35.7K shrs $195.65K | |
| 860 | ¥5.80 | -1.36% | +2.34% | ¥3.76B $519.49M · €452.94M | 7.82M shrs ¥45.34M | ||
| 861 | HK$17.90 | +0.51% | -2.61% | HK$4.03B $515.48M · €449.45M | 82.5K shrs HK$1.48M | ||
| 862 | ¥37.71 | -0.61% | +5.82% | ¥3.73B $515.28M · €449.27M | 889.35K shrs ¥33.54M | ||
| 863 | ₹844.25 | +1.13% | -1.50% | ₹42.82B $513.84M · €448.01M | 45.73K shrs ₹38.61M | ||
| 864 | ¥2614.00 | +8.60% | +2.76% | ¥76.55B $512.89M · €447.19M | 1.41M shrs ¥3.68B | ||
| 865 | ₹841.40 | +0.84% | +1.47% | ₹42.68B $512.10M · €446.50M | 1.47K shrs ₹1.23M | ||
| 866 | R$3.94 | -2.48% | -2.17% | R$2.84B $511.38M · €445.88M | — | ||
| 867 | ¥9.44 | +0.85% | -0.32% | ¥3.7B $510.77M · €445.34M | 2.17M shrs ¥20.47M | ||
| 868 | ₩8350.00 | -2.45% | -2.34% | ₩705.41B $507.90M · €442.84M | 115.7K shrs ₩966.1M | ||
| 869 | ¥22.77 | +1.25% | -1.36% | ¥3.66B $504.88M · €440.20M | 862.9K shrs ¥19.65M | ||
| 870 | ¥8.06 | +1.26% | +15.94% | ¥3.65B $504.24M · €439.65M | 1.44M shrs ¥11.59M | ||
| 871 | ¥15.92 | +0.70% | +2.80% | ¥3.63B $501.39M · €437.16M | 2.07M shrs ¥33.01M | ||
| 872 | ¥3350.00 | +1.21% | -6.31% | ¥74.82B $501.29M · €437.08M | 50.7K shrs ¥169.84M | ||
| 873 | ¥10.43 | +0.77% | -2.70% | ¥3.61B $498.10M · €434.29M | 2.03M shrs ¥21.2M | ||
| 874 | ¥3.50 | -3.85% | +1.20% | ¥3.6B $497.28M · €433.57M | 112.42M shrs ¥393.46M | ||
| 875 | $18.00 | -2.44% | -2.40% | $496.35M €432.76M | 192.4K shrs $3.46M | ||
| 876 | NT$48.70 | -2.31% | -0.22% | NT$16.01B $496.31M · €432.73M | 6.43M shrs NT$313.01M | ||
| 877 | ¥6.22 | +0.16% | +0.99% | ¥3.59B $495.45M · €431.99M | 9.05M shrs ¥56.3M | ||
| 878 | $3.93 | -5.07% | -15.71% | $493.02M €429.86M | 1.22M shrs $4.79M | ||
| 879 | NT$20.10 | -1.47% | +2.72% | NT$15.89B $492.71M · €429.59M | 803.3K shrs NT$16.15M | ||
| 880 | ¥2574.00 | -0.23% | +3.57% | ¥73.09B $489.71M · €426.98M | 65.4K shrs ¥168.34M | ||
| 881 | $9.92 | -16.57% | -0.59% | $488.54M €425.96M | 97.77K shrs $969.88K | ||
| 882 | ¥10.76 | +0.94% | -1.66% | ¥3.52B $486.01M · €423.75M | 2.88M shrs ¥31.03M | ||
| 883 | $8.96 | -8.38% | +28.81% | $485.08M €422.94M | 229.09K shrs $2.05M | ||
| 884 | ¥9.09 | +0.22% | +3.01% | ¥3.51B $483.89M · €421.90M | 10.14M shrs ¥92.18M | ||
| 885 | HK$27.76 | +2.28% | +7.04% | HK$3.76B $480.88M · €419.28M | 66K shrs HK$1.83M | ||
| 886 | NT$30.70 | +0.66% | +1.46% | NT$15.5B $480.53M · €418.98M | 1.02M shrs NT$31.25M | ||
| 887 |  Arvinas, Inc. ARVN🇺🇸USD | $7.42 | -4.13% | +0.74% | $478.75M €417.42M | 631.29K shrs $4.68M | |
| 888 | C$1.44 | -2.04% | -0.72% | C$646.68M $478.54M · €417.24M | 2.56M shrs C$3.68M | ||
| 889 | ¥25.47 | +0.47% | +1.40% | ¥3.45B $476.05M · €415.07M | 907.8K shrs ¥23.12M | ||
| 890 | NT$57.30 | +0.70% | -5.79% | NT$15.26B $473.14M · €412.53M | 296.37K shrs NT$16.98M | ||
| 891 | ¥10.19 | +0.20% | +1.76% | ¥3.41B $470.93M · €410.61M | 7.1M shrs ¥72.31M | ||
| 892 | ¥1860.00 | +1.09% | +3.98% | ¥69.89B $468.29M · €408.30M | 101.3K shrs ¥188.42M | ||
| 893 | ¥25.87 | -1.22% | +6.79% | ¥3.39B $467.30M · €407.44M | 4.79M shrs ¥123.86M | ||
| 894 | NT$101.50 | -0.49% | -6.37% | NT$15.04B $466.11M · €406.40M | 293.1K shrs NT$29.75M | ||
| 895 | ¥11.45 | -0.43% | -6.27% | ¥3.37B $465.63M · €405.98M | 5.57M shrs ¥63.83M | ||
| 896 | NT$55.40 | -5.46% | +0.79% | NT$15B $464.90M · €405.35M | 1.94M shrs NT$107.69M | ||
| 897 | ₹131.68 | -3.29% | +10.63% | ₹38.65B $463.82M · €404.41M | 2.1M shrs ₹276.25M | ||
| 898 | ₩44100.00 | -1.12% | -1.18% | ₩643.86B $463.58M · €404.19M | 15.94K shrs ₩702.87M | ||
| 899 | ₹131.55 | -3.48% | +12.71% | ₹38.61B $463.36M · €404.01M | 122K shrs ₹16.05M | ||
| 900 | $1.03 | -0.96% | +0.32% | $462.55M €403.30M | 13.38M shrs $13.78M |
Browse by Country
Europe
Asia